Calling methylene blue a 'proven' cognitive enhancer goes beyond the data
Methylene blue is having a moment in biohacking circles as a "mitochondrial cognitive enhancer." A detailed evidence review published September 22, 2026 concludes that the "proven" framing goes well beyond the data.
What is the best human cognition evidence?
A single 2016 randomized controlled trial of 26 adults, using a single dose, reported roughly 7% better memory retrieval on an fMRI task. That study has never been replicated in a clinical program. An IV study often cited alongside it was tiny and does not speak to oral dosing — the form most consumers actually use.
Is there anything new on the plus side?
Yes — a 2026 Aging study found methylene blue protects hair-follicle stem cells via mitochondrial support. Intriguing, but preliminary: a stem-cell mechanism in one tissue is not cognitive enhancement.
How does this connect to mitochondrial health?
Methylene blue genuinely interacts with mitochondrial electron transport — that is why it keeps attracting researchers. The watchdog point is about dose, route and claim: a real mitochondrial mechanism does not turn one small unreplicated trial into a proven brain upgrade.
Where the evidence stands
- Established: Methylene blue interacts with mitochondrial electron transport; the 2016 RCT exists and reported its results.
- Contested: 'Proven mitochondrial cognitive enhancer' claims exceed the data — one small unreplicated trial plus a tiny IV study.
- Preliminary: The 2026 hair-follicle stem-cell finding via mitochondrial support is early-stage research.